Selman Gencer

Selman Gencer

Auto-generated profile, based on publicly available information

Selman Gencer

Department of Internal Diseases, Faculty of Medicine Aksaray University Aksaray Turkey

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2024 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Open access
SGSelman Gencer
Selman Gencer
CGCihan Gür
Cihan Gür
MIMustafa İlEritürk
Mustafa İlEritürk
SKSefa Küçükler
Sefa Küçükler
NANurhan Akaras
Nurhan Akaras
FKFatih M. Kandemir
Fatih M. Kandemir
Arsenic is a toxic environmental pollutant heavy metal, and one of its critical target tissues in the body is the liver. Carvacrol is a natural phytocompound that stands out with its antioxidant, anti‐inflammatory, and antiapoptotic properties. The current study aims to investigate the protective feature of carvacrol against sodium arsenite‐induced liver toxicity. Thirty‐five Sprague‐Dawley male rats were divided into five groups: Control, Sodium arsenite (SA), CRV, SA + CRV25, and SA + CRV50. Sodium arsenite was administered via oral gavage at a dose of 10 mg/kg for 14 days, and 30 min later, CRV 25 or 50 mg/kg was administered via oral gavage. Oxidative stress, inflammation, apoptosis, autophagy damage pathways parameters, and liver tissue integrity were analyzed using biochemical, molecular, western blot, histological, and immunohistological methods. Carvacrol decreased sodium arsenite‐induced oxidative stress by suppressing malondialdehyde levels and increasing superoxide dismutase, catalase, glutathione peroxidase activities, and glutathione levels. Carvacrol reduced inflammation damage by reducing sodium arsenite‐induced increased levels of NF‐κB and the cytokines (TNF‐α, IL‐1β, IL‐6, RAGE, and NLRP3) it stimulates. Carvacrol also reduced sodium arsenite‐induced autophagic (Beclin‐1, LC3A, and LC3B) and apoptotic (P53, Apaf‐1, Casp‐3, Casp‐6, Casp‐9, and Bax) parameters. Carvacrol preserved sodium arsenite‐induced impaired liver tissue structure. Carvacrol alleviated toxic damage by reducing sodium arsenite‐induced increases in oxidative stress, inflammation, apoptosis, and autophagic damage parameters in rat liver tissues. Carvacrol was also beneficial in preserving liver tissue integrity.

9 June 2025 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Open access
SGSelman Gencer
Selman Gencer
NANurhan Akaras
Nurhan Akaras
HSHasan Simsek
Hasan Simsek
CGCihan Gür
Cihan Gür
MIMustafa İlEritürk
Mustafa İlEritürk
FKFatih Mehmet Kandemir
Fatih Mehmet Kandemir
Acrylamide (ACR) is a toxic chemical with a high carcinogenic risk that is released as a result of heating or processing foods at high temperatures. Chrysin (CHR) is a flavonoid that is naturally found in foods such as honey and passionflower and stands out with its antioxidant, anticancer, and anti‐inflammatory properties. This study aims to determine the protective effects of CHR in ACR‐induced hepatotoxicity. ACR was administered orally at a dose of 38.27 mg/kg; CHR (25 or 50 mg/kg) was administered orally for ten days. Biochemical and molecular methods were used to investigate oxidative stress, inflammation, and apoptotic markers in liver tissue. Additionally, histological methods were used to determine the liver tissue's structural and functional characteristics and autophagy. CHR treatment alleviated ACR‐induced oxidative stress by increasing antioxidants (SOD, CAT, GPx, GSH) and reducing increased oxidant MDA. CHR reduced inflammatory activity by inactivating NF‐κB and pro‐inflammatory cytokines. ACR‐induced increases in apoptotic Casp‐3, Casp‐6, Casp‐9, and Bax were reduced by CHR, while the decreased level of antiapoptotic Bcl‐2 was increased. It was also determined immunohistochemically that CHR inhibited autophagic Beclin‐1 activity. CHR was effective in reducing ACR‐induced hepatotoxicity damage and may be an effective treatment option.

5 July 2025 in Biochemical Pharmacology
Verified
Journal Article
Closed access
SGSelman Gencer
Selman Gencer
HŞHasan Şimşek
Hasan Şimşek
NANurhan Akaras
Nurhan Akaras
MIMustafa İleritürk
Mustafa İleritürk
CGCihan Gür
Cihan Gür
FKFatih Mehmet Kandemir
Fatih Mehmet Kandemir

25 October 2026 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
SGSelman Gencer
Selman Gencer
HSHasan Simsek
Hasan Simsek
Aims: This study aimed to compare serum arginase and nitric oxide (NO) levels in patients with type 2 diabetes mellitus (T2DM) with and without diabetic nephropathy (DN), evaluate their associations with renal function, and assess their diagnostic performance for DN.Methods: This retrospective case-control study included 89 patients with T2DM, comprising 45 patients with DN and 44 without nephropathy. Serum arginase and NO concentrations were measured using ELISA. Group comparisons were performed according to data distribution, and Benjamini-Hochberg false discovery rate correction was applied to secondary laboratory variables. Associations with creatinine, eGFR, and microalbuminuria were evaluated using age- and gender-adjusted partial Spearman correlations. Multivariable linear and logistic regression analyses were performed, and diagnostic performance was assessed using receiver operating characteristic analysis.Results: Serum arginase levels were higher in patients with DN than in those without nephropathy (49.92±14.28 vs. 43.67±12.35 pg/ml; p=0.030), whereas NO levels did not differ significantly [0.757 (0.670-0.952) vs. 0.741 (0.584-0.906) µmol/L; p=0.433]. After adjustment for age and gender, the between-group difference in arginase was attenuated (β=6.25, 95% CI: -0.13-12.64; p=0.055). Arginase remained modestly associated with DN in logistic regression (OR=1.049, 95% CI: 1.002-1.098; p=0.040). Neither biomarker showed significant adjusted correlations with renal parameters. Diagnostic discrimination was limited for arginase (AUC=0.610) and NO (AUC=0.548).Conclusion: Serum arginase may be modestly associated with DN, but neither arginase nor NO appears suitable as a stand-alone diagnostic biomarker.

1 July 2026 in Türk Doğa ve Fen Dergisi
Verified
Journal Article
Closed access
SGSelman Gencer
Selman Gencer
ÖKÖzge Kandemir
Özge Kandemir
NANurhan Akaras
Nurhan Akaras
HŞHasan Şimşek
Hasan Şimşek
This study evaluated polydatin's protective effects against methotrexate (MTX)-induced hepatotoxicity in rats. Thirty-five Wistar albino rats were divided into (n=7): Control, Polydatin-only (100 mg/kg), MTX-only (20 mg/kg), MTX + Polydatin (50 mg/kg), and MTX + Polydatin (100 mg/kg). Treatments lasted 7 days. MTX administration significantly increased serum AST/ALT levels, hepatic malondialdehyde (MDA), and pro-inflammatory/apoptotic markers (NF-κB, TNF-α, Bax, Caspase-3 mRNA), while decreasing anti-apoptotic Bcl-2 and tissue-repair signals (Wnt3 mRNA). Co-treatment with polydatin dose-dependently reversed these effects: the 100 mg/kg dose notably normalized AST/ALT and MDA levels more effectively than 50 mg/kg (p